Immunotherapies for Alzheimer’s disease
Todd E. Golde, Allan I. Levey
Abstract
Antibodies targeting amyloid-β aggregates slow decline in Alzheimer's disease.
Topics & Concepts
DiseaseAlzheimer's diseaseAmyloid (mycology)AntibodyAmyloid βMedicineNeuroscienceImmunologyBiologyPathologyAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesTryptophan and brain disorders